Studies chronic myeloid leukemia in children and adolescents
Describes chronic myeloid leukemia and its treatment in young patients under 18.
Plain-language title generated from the registry record
Registry title: International Chronic Myeloid Leukemia Pediatric Study
Key facts
- Where
- Görükle, TürkiyeSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and teenagers under 18 with Philadelphia positive and/or BCR-ABL positive chronic myeloid leukemia (CML), in any phase.
- Age
- Younger than 18 years.
- Sex
- Boys and girls can both join.
- Disease stage
- Chronic myeloid leukemia (CML) in all phases.
- Biomarker or test result
- Philadelphia positive and/or BCR-ABL positive.
Main reasons for not taking part
- People who were more than 18 years old when CML was diagnosed cannot join.
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- How old is the patient who may join a trial?
- What type of cancer has the patient been diagnosed with?
Source: NCT01281735, who can take part
Where in Türkiye
- Uludag University, Medical FacultyGörükle, TürkiyeContact: Adalet M GÜNEŞ, MDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Poitiers University Hospital
- Trial code
- NCT01281735
- Record updated
- 17 January 2024
- Original description
The purpose of the study is to describe and characterize CML in a large pediatric cohort of patients.Read full original descriptionShow less
INTERNATIONAL STUDY of Chronic Myeloid Leukaemia (CML) Treatment and Outcomes in Children and Adolescents
The purpose of the study is to describe and characterize CML in a large pediatric cohort of patients.
Inclusion: patients less than 18 years of age; diagnosed Philadelphia positive and/or BCR-ABL positive Chronic Myeloid Leukemia (CML) all phases.
Exclusion: patients more than 18 years of age at diagnosis of CML.